Replimune(US:REPL) Prnewswire·2025-09-15 12:45Core Points - The Gross Law Firm has issued a notice to shareholders of Replimune Group, Inc. regarding a class action lawsuit due to alleged misleading statements related to the IGNYTE trial [1] - The class period for the lawsuit is from November 22, 2024, to July 21, 2025, during which the defendants are accused of overstating the trial's prospects and failing to disclose material issues [1] - Shareholders are encouraged to register for the class action by September 22, 2025, to potentially become lead plaintiffs and participate in recovery [2] Company Allegations - The complaint alleges that the defendants made materially false and misleading statements about Replimune's business and operations, particularly regarding the IGNYTE trial's adequacy and control [1] - The FDA deemed the IGNYTE trial inadequate, which is central to the allegations against the defendants [1] Legal Firm Information - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [3] - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [3]